CASI - CASI inks deal to sell up to $20M common stock in an at the market offering

CASI Pharmaceuticals (NASDAQ:CASI) is trading ~3.7% lower in the post-market after the company announced an agreement with H.C. Wainwright to sell up to $20M of common stock. Per the deal signed on Oct. 29, H.C. Wainwright will operate as a sales agent for “at the market offering,” where company common stock at par value of $0.01 per share will be sold from time to time, according to company instructions. The share sales will be in line with the “shelf” registration statement filed by CASI (CASI) on Dec. 02, 2020.

For further details see:

CASI inks deal to sell up to $20M common stock in an at the market offering